GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GRAIL Inc (NAS:GRAL) » Definitions » Other Net Income (Loss)

GRAIL (GRAL) Other Net Income (Loss) : $0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is GRAIL Other Net Income (Loss)?

GRAIL's Other Net Income (Loss) for the three months ended in Dec. 2024 was $0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 was $0.0 Mil.

GRAIL's quarterly Other Net Income (Loss) increased from Jun. 2024 ($0.0 Mil) to Sep. 2024 ($0.0 Mil) but then declined from Sep. 2024 ($0.0 Mil) to Dec. 2024 ($0.0 Mil).

GRAIL's annual Other Net Income (Loss) stayed the same from Dec. 2022 ($0.0 Mil) to Dec. 2023 ($0.0 Mil) but then declined from Dec. 2023 ($0.0 Mil) to Dec. 2024 ($-0.0 Mil).


GRAIL Other Net Income (Loss) Historical Data

The historical data trend for GRAIL's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GRAIL Other Net Income (Loss) Chart

GRAIL Annual Data
Trend Dec18 Dec19 Dec22 Dec23 Dec24
Other Net Income (Loss)
- - - - -

GRAIL Quarterly Data
Dec18 Dec19 Jun20 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

GRAIL Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GRAIL Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of GRAIL's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


GRAIL Business Description

Traded in Other Exchanges
Address
1525 O’Brien Drive, Menlo Park, CA, USA, 94025
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.